The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Outinen, Tuula K ^a   Mäkelä, Satu M ^a,b   Ala Houhala, Ilpo O ^a,b   Huhtala, Heini S A ^c   Hurme, Mikko ^b   Paakkala, Antti S ^a   Pörsti, Ilkka H ^a,b   Syrjänen, Jaana T ^a,b   Mustonen, Jukka T ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; INTERLEUKIN 6; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEPHROPATHIA EPIDEMICA; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PUUMALA VIRUS; THROMBOCYTE COUNT; URINARY EXCRETION; BLOOD; BLOOD CELL COUNT; CHEMISTRY; HOSPITALIZATION; ISOLATION AND PURIFICATION; KIDNEY; MIDDLE AGED; PATHOLOGY; PLASMA; PROSPECTIVE STUDY; PROTEINURIA; URINE; VIROLOGY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD CELL COUNT; C-REACTIVE PROTEIN; CREATININE; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; INTERLEUKIN-6; KIDNEY; MALE; MIDDLE AGED; PLASMA; PROSPECTIVE STUDIES; PROTEINURIA; PUUMALA VIRUS; SEVERITY OF ILLNESS INDEX; URINE; YOUNG ADULT;

EID: 77952506401     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-132     Document Type: Article

References (37)

1. Schmaljohn CS, Dalrymple JM. Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology 1983, 131:482-491. 10.1016/0042-6822(83)90514-7, 6419460.
2. Kanerva M, Mustonen J, Vaheri A. Pathogenesis of Puumala and other hantavirus infections. Rev Med Virol 1998, 8:67-86. 10.1002/(SICI)1099-1654(199804/06)8:2<67::AID-RMV217>3.0.CO;2-U, 10398496.
3. Brummer-Korvenkontio M, Vaheri A, Hovi T, von Bonsdorff CH, Vuorimies J, Manni T, Penttinen K, Oker-Blom N, Lähdevirta J. Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis 1980, 141:131-134.
4. Vapalahti O, Mustonen J, Lundkvist T, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis 2003, 3:653-661. 10.1016/S1473-3099(03)00774-6, 14522264.
5. Brummer-Korvenkontio M, Vapalahti O, Henttonen H, Koskela P, Kuusisto P, Vaheri A. Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis 1999, 31:427-435. 10.1080/00365549950163941, 10576121.
6. Mustonen J, Partanen J, Kanerva M, Pietilä K, Vapalahti O, Pasternack A, Vaheri A. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 1996, 49:217-221. 10.1038/ki.1996.29, 8770970.
7. Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Partanen J, Vapalahti O, Vaheri A, Pasternack A. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis 2002, 186:843-846. 10.1086/342413, 12198621.
8. Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis 1994, 26:7-13. 10.3109/00365549409008583, 7910705.
9. Lähdevirta J. Nephropathia epidemica in Finland. A clinical histological and epidemiological study. Ann Clin Res 1971, 3:1-54.
10. Linderholm M, Billstrom A, Settergren B, Tärnvik A. Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection 1992, 20:263-266. 10.1007/BF01710791, 1358824.
11. Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A. Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol 1996, 46:369-378.
12. Paakkala A, Lempinen L, Paakkala T, Huhtala H, Mustonen J. Medical imaging in nephropathia epidemica and their clinical correlations. Eur J Intern Med 2004, 15:284-290. 10.1016/j.ejim.2004.07.001, 15450985.
13. Cosgriff TM. Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 1991, 13:97-107.
14. Temonen M, Vapalahti O, Holthöfer H, Brummer-Korvenkontio M, Vaheri A, Lankinen H. Susceptibility of human cells to Puumala virus infection. J Gen Virol 1993, 74(Pt 3):515-518. 10.1099/0022-1317-74-3-515, 8445370.
15. Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Koivisto AM, Vaheri A, Pasternack A. Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis 2004, 43:809-816. 10.1053/j.ajkd.2003.12.044, 15112171.
16. Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthöfer H. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 1996, 78:47-55. 10.1006/clin.1996.0007, 8599883.
17. Linderholm M, Ahlm C, Settergren B, Waage A, Tärnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996, 173:38-43.
18. Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, Waite DC, Koster FT, Ennis FA. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 1999, 179:295-302. 10.1086/314597, 9878011.
19. Klingström J, Plyusnin A, Vaheri A, Lundkvist T. Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol 2002, 76:444-449. 10.1128/JVI.76.1.444-449.2002, 135710, 11739712.
20. Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. Embo J 1989, 8:3773-3779. 402063, 2555173.
21. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 2001, 64:262-268. 10.1002/jmv.1045, 11424113.
22. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998, 101:643-649. 10.1172/JCI1355, 508608, 9449698.
23. Vapalahti O, Lundkvist T, Kallio-Kokko H, Paukku K, Julkunen I, Lankinen H, Vaheri A. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J Clin Microbiol 1996, 34:119-125. 228743, 8748286.
24. Takala A, Lähdevirta J, Jansson SE, Vapalahti O, Orpana A, Karonen SL, Repo H. Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. J Infect Dis 2000, 181:1964-1970. 10.1086/315522, 10837176.
25. Winter PM, Dung NM, Loan HT, Kneen R, Wills B, le Thu T, House D, White NJ, Farrar JJ, Hart CA, Solomon T. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis 2004, 190:1618-1626. 10.1086/423328, 15478067.
26. Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG, Piedra PA. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis 2007, 195:1532-1540. 10.1086/515575, 17436234.
27. Elliott MB, Welliver RC, Laughlin TS, Pryharski KS, LaPierre NA, Chen T, Souza V, Terio NB, Hancock GE. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol 2007, 79:447-456. 10.1002/jmv.20830, 17311330.
28. Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 2006, 74:142-147.
29. Avila-Aguero ML, Avila-Aguero CR, Um SL, Soriano-Fallas A, Canas-Coto A, Yan SB. Systemic host inflammatory and coagulation response in the Dengue virus primo-infection. Cytokine 2004, 27:173-179. 10.1016/j.cyto.2004.05.007, 15304247.
30. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004, 65:1357-1365. 10.1111/j.1523-1755.2004.00512.x, 15086475.
31. Kadiroglu AK, Sit D, Atay AE, Kayabasi H, Altintas A, Yilmaz ME. The evaluation of effects of demographic features, biochemical parameters, and cytokines on clinical outcomes in patients with acute renal failure. Ren Fail 2007, 29:503-508. 10.1080/08860220701274991, 17497476.
32. Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum 2005, 52:642-650. 10.1002/art.20846, 15692982.
33. Rodriguez W, Mold C, Kataranovski M, Hutt JA, Marnell LL, Verbeek JS, Du Clos TW. C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors. J Immunol 2007, 178:530-538.
34. Rodriguez W, Mold C, Marnell LL, Hutt J, Silverman GJ, Tran D, Du Clos TW. Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. Arthritis Rheum 2006, 54:325-335. 10.1002/art.21556, 16385552.
35. Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J, Powell RJ, Isenberg DA, Walport MJ, Vyse TJ. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004, 13:137-147. 10.1093/hmg/ddh021, 14645206.
36. Penttinen K, Lähdevirta J, Kekomäki R, Ziola B, Salmi A, Hautanen A, Lindström P, Vaheri A, Brummer-Korvenkontio M, Wager O. Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. J Infect Dis 1981, 143:15-21.
37. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 2005, 351:17-29. 10.1016/j.cccn.2004.08.018, 15563869.